These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 35902046)

  • 21. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
    Mekers VE; Kho VM; Ansems M; Adema GJ
    Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interactions between cGAS-STING pathway and pathogens.
    Cheng Z; Dai T; He X; Zhang Z; Xie F; Wang S; Zhang L; Zhou F
    Signal Transduct Target Ther; 2020 Jun; 5(1):91. PubMed ID: 32532954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing.
    Chen Q; Sun L; Chen ZJ
    Nat Immunol; 2016 Sep; 17(10):1142-9. PubMed ID: 27648547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cGAS-STING signalling in liver diseases.
    Chen R; Du J; Zhu H; Ling Q
    JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers.
    Ke X; Hu T; Jiang M
    FASEB J; 2022 Jan; 36(1):e22029. PubMed ID: 34907606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases.
    Pan J; Fei CJ; Hu Y; Wu XY; Nie L; Chen J
    Zool Res; 2023 Jan; 44(1):183-218. PubMed ID: 36579404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.
    Kato Y; Park J; Takamatsu H; Konaka H; Aoki W; Aburaya S; Ueda M; Nishide M; Koyama S; Hayama Y; Kinehara Y; Hirano T; Shima Y; Narazaki M; Kumanogoh A
    Ann Rheum Dis; 2018 Oct; 77(10):1507-1515. PubMed ID: 29945921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damage-triggered activation of cGAS-STING pathway induces apoptosis in human keratinocyte HaCaT cells.
    Li C; Liu W; Wang F; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Mol Immunol; 2021 Mar; 131():180-190. PubMed ID: 33423764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes.
    Wang J; Dai M; Cui Y; Hou G; Deng J; Gao X; Liao Z; Liu Y; Meng Y; Wu L; Yao C; Wang Y; Qian J; Guo Q; Ding H; Qu B; Shen N
    Arthritis Rheumatol; 2018 Dec; 70(12):2036-2045. PubMed ID: 29806091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway.
    Bose D; Su Y; Marcus A; Raulet DH; Hammond MC
    Cell Chem Biol; 2016 Dec; 23(12):1539-1549. PubMed ID: 27889408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway.
    Tian M; Liu W; Zhang Q; Huang Y; Li W; Wang W; Zhao P; Huang S; Song Y; Shereen MA; Qin M; Liu Y; Wu K; Wu J
    Cell Rep; 2020 Oct; 33(3):108297. PubMed ID: 33086059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cGAS-STING signaling in ischemic diseases.
    Lei C; Tan Y; Ni D; Peng J; Yi G
    Clin Chim Acta; 2022 Jun; 531():177-182. PubMed ID: 35398249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.
    Sun L; Wu J; Du F; Chen X; Chen ZJ
    Science; 2013 Feb; 339(6121):786-91. PubMed ID: 23258413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cGAS Activity and Downstream Signaling.
    Joshi B; Joshi JC; Mehta D
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatitis B virus replication by activation of the cGAS-STING pathway.
    He J; Hao R; Liu D; Liu X; Wu S; Guo S; Wang Y; Tien P; Guo D
    J Gen Virol; 2016 Dec; 97(12):3368-3378. PubMed ID: 27902332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING.
    Ablasser A; Goldeck M; Cavlar T; Deimling T; Witte G; Röhl I; Hopfner KP; Ludwig J; Hornung V
    Nature; 2013 Jun; 498(7454):380-4. PubMed ID: 23722158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intervention of cGAS‒STING signaling in sterile inflammatory diseases.
    Hong Z; Mei J; Guo H; Zhu J; Wang C
    J Mol Cell Biol; 2022 May; 14(2):. PubMed ID: 35084490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.